Frontage Laboratories digs deeper in China
By Peter Mansell 23 February 2009
Frontage Laboratories, a US-based provider of bio-analytical, preclinical, clinical and drug development services, is deepening its involvement in
The revised agreement gives Frontage a newly constructed, 1,800sq metre R&D centre as well as continued access to Beijing Pharma’s Good Manufacturing Practice (GMP)-standard production areas. The company, which describes itself as a US-China contract research organisation, will also collaborate with Beijing Pharma on developing 12 generic drug products over the next three to five years, which will be marketed in
Frontage has been operating in
Headquartered in